John Flanagan

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: SEXUAL MEDICINE. 2020;8(2):243-250
Normal Testosterone but Higher Luteinizing Hormone Plasma Levels in Men With Hypersexual Disorder
Chatzittofis A; Bostrom AE; Oberg KG; Flanagan JN; Schioth HB; Arver S; Jokinen J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2020;105(3):dgz247-E813
Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals
Wiik A; Lundberg TR; Rullman E; Andersson DP; Holmberg M; Mandic M; Brismar TB; Leinhard OD; Chanpen S; Flanagan JN; Arver S; Gustafsson T
Article: EPIGENETICS. 2020;15(1-2):145-160
Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genes
Bostrom AE; Chatzittofis A; Ciuculete D-M; Flanagan JN; Krattinger R; Bandstein M; Mwinyi J; Kullak-Ublick GA; Oberg KG; Arver S; Schioth HB; Jokinen J
Article: JOURNAL OF SEXUAL MEDICINE. 2018;15(11):1537-1546
Androgen Receptor Polymorphism and Female Sexual Function and Desire
Wahlin-Jacobsen S; Flanagan JN; Pedersen AT; Kristensen E; Arver S; Giraldi A
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2018;15(6):511-518
Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction
Wang A; Arver S; Flanagan J; Gyberg V; Nasman P; Ritsinger V; Mellbin LG
Article: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2018;10:148-153
Metabolic and functional changes in transgender individuals following cross-sex hormone treatment: Design and methods of the GEnder Dysphoria Treatment in Sweden (GETS) study
Wiik A; Andersson DP; Brismar TB; Chanpen S; Dhejne C; Ekstrom TJ; Flanagan JN; Holmberg M; Kere J; Lilja M; Lindholm ME; Lundberg TR; Maret E; Melin M; Olsson SM; Rullman E; Wahlen K; Arver S; Gustafsson T
Article: PSYCHONEUROENDOCRINOLOGY. 2017;80:67-73
Methylation of HPA axis related genes in men with hypersexual disorder
Jokinen J; Bostrom AE; Chatzittofis A; Ciuculete DM; Oberg KG; Flanagan JN; Arver S; Schioth HB
Article: HORMONE AND METABOLIC RESEARCH. 2015;47(9):668-673
The Response to Gonadotropin-Releasing Hormone and hCG in Men with Prior Chronic Androgen Steroid Abuse and Clinical Hypogonadism
Flanagan JN; Lehtihet M
Article: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2013;138:427-434
MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G₀/G₁ with upregulation of p21 and p27 and downregulation of telomerase
Chiang K-C; Yeh C-N; Hsu J-T; Chen L-W; Kuo S-F; Sun C-C; Huang C-C; Pang J-HS; Flanagan JN; Takano M; Kittaka A; Juang H-H; Yang S-W; Chen TC
Article: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2011;127(3-5):269-275
Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D₃ with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells
Iglesias-Gato D; Zheng S; Flanagan JN; Jiang L; Kittaka A; Sakaki T; Yamamoto K; Itoh T; LeBrasseur NK; Norstedt G; Chen TC
Article: JOURNAL OF APPLIED PHYSIOLOGY. 2010;109(3):721-727
Effects of 3 days unloading on molecular regulators of muscle size in humans
Gustafsson T; Osterlund T; Flanagan JN; von Walden F; Trappe TA; Linnehan RM; Tesch PA
Article: OBESITY. 2010;18(3):434-440
Mice deficient in phosphofructokinase-M have greatly decreased fat stores.
Getty-Kaushik L; Viereck JC; Goodman JM; Guo Z; LeBrasseur NK; Richard A-MT; Flanagan JN; Yaney GC; Hamilton JA; Tornheim K
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2009;94(8):3003-3009
Role of Follistatin in Promoting Adipogenesis in Women
Flanagan JN; Linder K; Mejhert N; Dungner E; Wahlen K; Decaunes P; Ryden M; Bjorklund P; Arver S; Bhasin S; Bouloumie A; Arner P; Dahlman I
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2008;296(1-2):32-40
Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes.
Gupta V; Bhasin S; Guo W; Singh R; Miki R; Chauhan P; Choong K; Tchkonia T; Lebrasseur NK; Flanagan JN; Hamilton JA; Viereck JC; Narula NS; Kirkland JL; Jasuja R
Article: ANTICANCER RESEARCH. 2008;28(4A):2009-2013
Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor.
Wang L; Persons KS; Jamieson D; Flanagan JN; Hsu HH; Holick MF; Luo Z; Sakaki T; Urushino N; Faller DV; Chen TC
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2008;283(14):9136-9145
The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/β-catenin signaling pathways
Guo W; Flanagan J; Jasuja R; Kirkland J; Jiang L; Bhasin S
Article: ENDOCRINE PRACTICE. 2008;14(2):168-174
Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction.
Flanagan JN; Pineda P; Knapp PE; De Las Morenas A; Lee SL; Braverman LE
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2007;293(3):E794-E801
Tissue-dependent loss of phosphofructokinase-M in mice with interrupted activity of the distal promoter: impairment in insulin secretion
Richard A-MT; Webb D-L; Goodman JM; Schultz V; Flanagan JN; Getty-Kaushik L; Deeney JT; Yaney GC; Dunaway GA; Berggren P-O; Tornheim K
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2007;92(7):2793-2802
Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss.
Montano M; Flanagan JN; Jiang L; Sebastiani P; Rarick M; LeBrasseur NK; Morris CA; Jasuja R; Bhasin S
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2007;292(1):E298-E307
Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns.
Tchkonia T; Lenburg M; Thomou T; Giorgadze N; Frampton G; Pirtskhalava T; Cartwright A; Cartwright M; Flanagan J; Karagiannides I; Gerry N; Forse RA; Tchoukalova Y; Jensen MD; Pothoulakis C; Kirkland JL
Article: CARCINOGENESIS. 2004;25(6):967-971
The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D.
Young MV; Schwartz GG; Wang L; Jamieson DP; Whitlatch LW; Flanagan JN; Lokeshwar BL; Holick MF; Chen TC
Article: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2004;89-90(1-5):127-130
Regulation of 25-hydroxyvitamin D-1alpha-hydroxylase by epidermal growth factor in prostate cells.
Wang L; Flanagan JN; Whitlatch LW; Jamieson DP; Holick MF; Chen TC
Article: JOURNAL OF CELLULAR BIOCHEMISTRY. 2003;88(2):315-322
Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer.
Chen TC; Wang L; Whitlatch LW; Flanagan JN; Holick MF
Article: RECENT RESULTS IN CANCER RESEARCH. 2003;164:157-167
Regulation of the 25-hydroxyvitamin D-1alpha-hydroxylase gene and its splice variant.
Flanagan JN; Wang L; Tangpricha V; Reichrath J; Chen TC; Holick MF
Article: JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2002;81(2):135-140
25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer.
Whitlatch LW; Young MV; Schwartz GG; Flanagan JN; Burnstein KL; Lokeshwar BL; Rich ES; Holick MF; Chen TC
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2001;116(6):910-914
Enhancing 1 alpha-hydroxylase activity with the 25-hydroxyvitamin D-1 alpha-hydroxylase gene in cultured human keratinocytes and mouse skin.
Flanagan JN; Whitlatch LW; Chen TC; Zhu XH; Holick MT; Kong XF; Holick MF
Article: LANCET. 2001;357(9269):1673-1674
25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue.
Tangpricha V; Flanagan JN; Whitlatch LW; Tseng CC; Chen TC; Holt PR; Lipkin MS; Holick MF
Article: CELL. 1998;93(3):445-454
Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.
Nachtigal MW; Hirokawa Y; Enyeart-VanHouten DL; Flanagan JN; Hammer GD; Ingraham HA
Visa fler

Alla övriga publikationer

Other: BASIC AND CLINICAL ANDROLOGY. 2018;28:13
Male reproductive health statement (XIIIth international symposium on Spermatology, may 9th-12th 2018, Stockholm, Sweden
Levine H; Mohri H; Ekbom A; Ramos L; Parker G; Roldan E; Jovine L; Koelle S; Lindstrand A; Immler S; Mortimer S; Mortimer D; van der Horst G; Ishijima S; Aneck-Hahn N; Baldi E; Menkveld R; Rothmann SA; Giwercman A; Giwercman Y; Holmberg M; Kvist U; Bjorndahl L; Holmberg R; Arver S; Flanagan J; Drevet JR
Corrigendum: ANTICANCER RESEARCH. 2010;30(3):1033
Evaluation of 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 as a Therapeutic Agent for Androgen-dependent Prostate Cancer (vol 29, pg 3547, 2009)
Flanagan JN; Zheng SS; Chiang KC; Kittaka A; Sakak T; Nakabayashi S; Zhao XS; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
Corrigendum: ANTICANCER RESEARCH. 2010;30(1):277
Evaluation of 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D-3 as a Therapeutic Agent for Androgen-dependent Prostate Cancer (vol 29, pg 3547, 2009)
Flanagan JN; Zheng SS; Chiang KC; Kittaka A; Sakak T; Nakabayashi S; Zhao XS; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
Published conference paper: ANTICANCER RESEARCH. 2009;29(9):3547-3553
Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
Flanagan JN; Zheng S; Chiang K-C; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
Editorial: JOURNAL OF UROLOGY. 2009;181(4):1824
Effects of Dihydrotestosterone on Differentiation and Proliferation of Human Mesenchymal Stem Cells and Preadipocytes Editorial Comment
Gupta V; Bhasin S; Guo W; Singh R; Miki R; Chauhan P; Choong K; Tchkonia T; Lebrasseur NK; Flanagan JN; Hamilton JA; Viereck JC; Narula NS; Kirkland JL; Jasuja R
Published conference paper: ANTICANCER RESEARCH. 2006;26(4A):2567-2572
Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.
Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC
Published conference paper: ANTICANCER RESEARCH. 2006;26(4A):2615-2620
Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue.
Friedrich M; Diesing D; Cordes T; Fischer D; Becker S; Chen TC; Flanagan JN; Tangpricha V; Gherson I; Holick MF; Reichrath J
Review: RECENT RESULTS IN CANCER RESEARCH. 2003;164:223-237
Vitamin D autocrine system and prostate cancer.
Wang L; Whitlatch LW; Flanagan JN; Holick MF; Chen TC

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI